ArticleScientific reports2026
Risk factors for visual field progression during 10-year follow-up in newly diagnosed exfoliation glaucoma patients.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To identify risk factors associated with visual field progression over long-term follow-up (10 years) in patients newly diagnosed with exfoliation glaucoma. This was a non-randomised, prospective cohort study including patients newly diagnosed with exfoliation glaucoma. Visual field progression was assessed using three methods mean deviation (MD), visual field index (VFI), and guided progression analysis (GPA). Baseline variables to be evaluated included intraocular pressure (IOP), sex, age, visual fields, uni- or bilateral presentation, visual acuity, lens status (phakic/pseudophakic), central corneal thickness (CCT), optic nerve status, and gonioscopy findings. Additionally, a questionnaire on, hypertension, diabetes, migraine, smoking, and family history of glaucoma. Multivariable regression analyses were performed to identify risk factors. A total of 58 patients completed the 10-year follow-up. The IOP at inclusion was 32.06 (± 6.05) mmHg. In the MD model, significant risk factors for progression included older age (p = 0.002), smoking (p = 0.004), phakic lens status (p < 0.001), and lower CCT (p = 0.02). In the VFI model, significant risk factors were older age (p = 0.009) and smoking (p = 0.04). In the GPA model, risk factors included older age (p = 0.001) and smoking (p = 0.01). Older age at diagnosis and a history of smoking were found to be significantly associated with an increased risk of long-term visual field progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.